EASTERN COOPERATIVE ONCOLOGY GROUP

东方肿瘤合作组

• 批准号: 3555876
• 负责人: DANIEL D KARP
• 金额: $ 25.25万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 1982
• 资助国家: 美国
• 起止时间: 1982-12-01 至 1994-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3555876
• 关键词: Burkitt's lymphoma; Epstein Barr virus; acute leukemia; acute lymphocytic leukemia; antineoplastics; biological response modifiers; bladder neoplasm; bone marrow transplantation; brain neoplasms; breast neoplasm /cancer diagnosis; breast neoplasms; cancer registry /resource; cancer risk; carmustine; clinical trials; colon neoplasms; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; cytosine arabinoside; deoxycoformycin; dexamethasone; drug administration routes; drug adverse effect; drug metabolism; environment related neoplasm /cancer; flow cytometry; fluorouracil; glioma; head /neck neoplasm; histopathology; hormone receptor; human subject; human therapy evaluation; immunofluorescence technique; immunologic skin test; interleukin 2; iridium; kidney neoplasms; lectin; lung neoplasms; lymphoma; meeting /conference /symposium; melanoma; metastasis; methotrexate; multiple myeloma; myeloproliferative neoplasm; nasopharyngeal neoplasms; neoplasm /cancer chemotherapy; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer radionuclide therapy; neoplasm /cancer surgery; oncogenes; prednisone; prostate neoplasms; rectum neoplasms; skin neoplasms; testis neoplasms; tumor promoters; vitamin D

The Tufts ECOG Network is a unified group of hospitals dedicated to improving the care of cancer patients through the entry of patients onto clinical trials. The Tufts Group has provided increasing accrual onto clinical trials and increasing scientific input to ECOG. Our Network has grown consistently in the past, there are 22 affiliated hospitals in Massachusetts, Rhode Island and Connecticut. This provides us with the ability to have a strong impact upon the care of patients in New England. The Tufts Network is unique because its major components are three of the main teaching hospitals for medical schools in New England. This prevalence of academia in the Group providing the Tufts Network with incomparable capability to be a significant contributor to the development of the basic science necessary for clinical cancer research. The leaders of the Tufts Network; Dr. Thomas J. Smith and Dr. Nicholas Robert have positions of leadership in the ECOG, providing direction to the Group. Their interest in clinical trials has provided the impetus for the growth of clinical research both at New England Medical Center and across the Tufts Network.

塔夫茨ECOG网络是一群统一的医院 通过进入 患者进入临床试验。 塔夫茨集团提供了 增加应计入临床试验并增加科学试验 输入ECOG。 我们的网络过去一直在增长， 罗德岛州马萨诸塞州有22家附属医院 和康涅狄格州。 这为我们提供了一个 对新英格兰患者护理的强烈影响。 塔夫茨网络是独一无二的，因为其主要组件是三个 新英格兰医学院的主要教学医院。 在提供簇的小组中学术界的这种流行率 具有无与伦比的能力的网络是重要的 开发必要的基础科学的贡献者 用于临床癌症研究。 塔夫茨网络的领导者；托马斯·史密斯博士和博士 尼古拉斯·罗伯特（Nicholas Robert）在ECOG中具有领导地位， 向小组提供方向。 他们对临床的兴趣 试验为临床研究的增长提供了动力 在新英格兰医疗中心和塔夫茨网络上。